Mycotechnology and IFF join forces in Europe to create better food system
Mycotechnology, a company using mycelia, the roots of mushrooms, and IFF have formed a partnership…
November 29, 2022 - 2 minutes
Collaboration deals
Deep Science Ventures and AbbVie to create companies to target inflammatory diseases
Deep Science Ventures (DSV), a London-based venture creator, is teaming up with AbbVie, a global…
November 28, 2022 - 2 minutes
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
November 28, 2022 - 3 minutes
XtalPi and CK Life Sciences partner on tumor vaccine R&D
XtalPi has entered into a strategic collaboration with CK Life Sciences, a member of the…
November 25, 2022 - 3 minutes
BC Platforms partners on AI-driven EU cancer data project
BC Platforms (BCP), a provider of healthcare data management and analytics, has been chosen as…
November 24, 2022 - 2 minutes
BIA and Exopharm sign joint research agreement to develop integrated technology
Slovenian-based Sartorius BIA Separations (BIA), a bio-chromatography company, and Australia's Exopharm Ltd., a company working…
November 23, 2022 - 4 minutes
Jnana Therapeutics raises $107M for PKU program and announces new Roche partnership
Jnana Therapeutics has entered into a second collaboration and license agreement with Roche for the…
November 15, 2022 - 4 minutes
Bel Group and Standing Ovation partner on cheese proteins
Dairy giant Bel Group and start-up Standing Ovation are partnering on incorporating casein milk protein…
November 15, 2022 - 2 minutes
Biotheus enters agreement with Hansoh Pharma for bispecific antibody
Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for…
November 15, 2022 - 2 minutes
BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…
November 15, 2022 - 2 minutes
Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease
Minoryx Therapeutics and Neuraxpharm Group have announced a strategic alliance for the European rights to…
November 14, 2022 - 3 minutes
